Camp4 Therapeutics (CAMP) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Camp4 Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $99K and 2 sold $2.5M of CAMP stock on the open market, including a cluster buy that began Aug 3, 2026.
Get emailed when insiders cluster-buy stocks like CAMP
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CAMP insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $99K | 5 | $2.5M | 6 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 Camp4 Therapeutics Corp insiders reported open-market purchases totaling $99K, while 2 insiders reported sales totaling $2.5M. The most recent cluster buy began on Aug 3, 2026, when 4 insiders bought a combined $59K. 0 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
CAMP stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 2SEC | Kelly GoldCFO | Buy | 10,000new position | $3.96 | $40K | -4.8% | — |
| Aug 31SEC | Andrew J. SchwabDirector | Sell | 400,0002,033,270 held (−16%) | $4.04 | $1.6M | -6.7% | — |
| Aug 26SEC | Andrew J. SchwabDirector | Sell | 102,433,270 held (−0%) | $4.50 | $45 | -16.2% | — |
| Aug 21SEC | Andrew J. SchwabDirector | Sell | 114,7002,465,298 held (−4%) | $4.54 | $521K | -17.0% | — |
| Aug 21SEC | Andrew J. SchwabDirector | Sell | 45,1472,579,998 held (−2%) | $4.76 | $215K | -20.8% | — |
| Aug 21SEC | Andrew J. SchwabDirector | Sell | 32,0182,433,280 held (−1%) | $4.50 | $144K | -16.2% | — |
| Aug 19SEC | Daniel TardiffChief Scientific Officer | Sell | 1,738 | $4.76 | $8K | -20.8% | — |
| Aug 5SEC | Richard A YoungDirector | Buy | 16,378186,388 held (+10%) | $1.65 | $27K | +128.5% | — |
| Aug 5SEC | Kelly GoldCFO | Buy | 6,55174,428 held (+10%) | $1.65 | $11K | +128.5% | — |
| Aug 5SEC | Josh Mandel-brehmCEO | Buy | 6,551284,968 held (+2%) | $1.65 | $11K | +128.5% | — |
| Aug 5SEC | Yuri MaricichChief Medical Officer | Buy | 6,55112,611 held (+108%) | $1.65 | $11K | +128.5% | — |
Insiders at Camp4 Therapeutics Corp
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Andrew J. SchwabDirector | — | $2.5M | Aug 31, 2026 | — |
| Kelly GoldCFO | $50K | — | Sep 2, 2026 | — |
| Richard A YoungDirector | $27K | — | Aug 5, 2026 | — |
| Josh Mandel-brehmCEO | $11K | — | Aug 5, 2026 | — |
| Yuri MaricichChief Medical Officer | $11K | — | Aug 5, 2026 | — |
| Daniel TardiffChief Scientific Officer | — | $8K | Aug 19, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
CAMP stock: common questions
Are Camp4 Therapeutics Corp insiders buying CAMP stock?
In the past 12 months, 4 insiders reported open-market purchases of CAMP worth $99K. The latest was CFO Kelly Gold bought $40K of CAMP at $3.96 — largest purchase by this insider in our records; opens a new position.
Are Camp4 Therapeutics Corp insiders selling CAMP stock?
2 insiders reported sales worth $2.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CAMP's 52-week range?
Over the past year CAMP has traded between $2.90 and $7.13. It last closed at $3.77 on Oct 9, 2026.